PACS — PACS Group, Inc.

PACS Group Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $1.3 billion for Q3 2025, a 31% increase year-over-year.
• Adjusted EBITDAR: $226.6 million for Q3.
• Adjusted EBITDA: $131.5 million for Q3.
• Net Income: $52.3 million for Q3.
• Diluted Earnings Per Share: $0.32 for Q3.
• Year-to-Date Revenue: $3.9 billion, a 36% increase compared to the same period in 2024.
• Year-to-Date Adjusted EBITDA: $363.0 million.
• Total Facility Occupancy: 89%, with mature facilities at 95% occupancy.

2. Strategic Updates and Business Highlights

• PACS has completed its restatement and strengthened internal controls, marking a renewed commitment to transparency and governance.
• The company operates 320 facilities across the U.S., with a focus on delivering high-quality skilled nursing care.
• PACS has successfully integrated 106 acquisitions in 2024, including 94 in the second half of the year, adding over 8,700 beds.
• 68.6% of PACS facilities are rated 4 or 5 stars by CMS, reflecting a commitment to clinical excellence.
• The company has a strong pipeline for leadership development, with a retention rate of 78% for its Administrator in Training (AIT) program.

3. Forward Guidance and Outlook

• For full-year 2025, PACS expects revenue between $5.25 billion and $5.35 billion, projecting a 30% increase over 2024.
• Adjusted EBITDA guidance for 2025 is between $480 million and $490 million.
• The company anticipates continued growth driven by demographic trends and operational improvements.

4. Bad News, Challenges, or Points of Concern

• Despite strong overall performance, occupancy in newly acquired facilities is lower at 81%, down from 83% in the prior year, indicating challenges in stabilization post-acquisition.
• The company faced significant operational challenges during the audit process, which may have impacted relationships with key referral sources and payers, although they report that relationships remain strong.
• There is a risk associated with the integration of a large number of acquisitions, which may strain resources and operational capabilities.

5. Notable Q&A Insights

• Management emphasized the importance of local market strategies and strong referral relationships, which have held up well despite recent challenges.
• There is a focus on maintaining a disciplined approach to M&A, with a historical average of 20 acquisitions per year, although they exceeded this in 2024.
• The company is optimistic about embedded EBITDA opportunities in new and ramping cohorts, with expectations that these will improve as facilities stabilize.
• Medicaid reimbursement strategies are being closely monitored, with management expressing confidence in their ability to navigate changes and capitalize on opportunities in various states.

Overall, PACS Group showcased strong financial performance in Q3 2025, with strategic initiatives aimed at enhancing operational excellence and growth, while also addressing challenges related to integration and occupancy in newly acquired facilities.